支架内新生动脉粥样硬化基础与临床研究进展

doi:10.12066/j.issn.1007-2861.2134

Abstract

Abstract:

In-stent neoatherosclerosis (ISNA) has been identified as a major contributing factor to late stent failure resulting from stent thrombosis (ST) and in-stent restenosis (ISR). However, the accurate mechanism of ISNA remains unknown to this day and the absence of effective therapeutic strategy remains an essential issue to be solved. Hence, future studies should focus on the mechanism of ISNA progression and the treatment of ISNA, which are of great clinical significance for improving the prognosis of patients following stent implantation. In this paper, the basic and clinic advances of ISNA have been addressed.

Key words: in-stent neoatherosclerosis, stent thrombosis, in-stent restenosis, drug-eluting stents, optical coherence tomography

CLC Number:

R541.4

PENG Xiang , TIAN Jinwei . Basic and clinic advances of in-stent neoatherosclerosis[J]. Journal of Shanghai University（Natural Science Edition）, 2019, 25(3): 399-405.

References 30

[1]	Zhao D, Liu J, Wang M , et al. Epidemiology of cardiovascular disease in China: current features and implications[J]. Nature Reviews Cardiology, 2019,16:203-212. doi: 10.1038/s41569-018-0119-4 pmid: 30467329
[2]	Park S J, Kang S J, Virmani R , et al. In-stent neoatherosclerosis: a final common pathway of late stent failure[J]. Journal of the American College of Cardiology, 2012,59:2051-2057. doi: 10.1016/j.jacc.2011.10.909
[3]	Adriaenssens T, Joner M, Godschalk T C , et al. Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PRESTIGE consortium (prevention of late stent thrombosis by an interdisciplinary global european effort)[J]. Circulation, 2017,136:1007-1021. doi: 10.1161/CIRCULATIONAHA.117.026788 pmid: 28720725
[4]	Kang S J, Mintz G S, Park D W , et al. Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis[J]. The American Journal of Cardiology, 2010,106:1561-1565. doi: 10.1016/j.amjcard.2010.07.031 pmid: 21094355
[5]	Nakazawa G, Otsuka F, Nakano M , et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents[J]. Journal of the American College of Cardiology, 2011,57:1314-1322. doi: 10.1016/j.jacc.2011.01.011
[6]	Higo T, Ueda Y, Oyabu J , et al. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study[J]. JACC Cardiovascular Imaging, 2009,2(5):616-624. doi: 10.1016/j.jcmg.2008.12.026 pmid: 19442950
[7]	Otsuka F, Byrne R A, Yahagi K , et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment[J]. European Heart Journal, 2015,36:2147-2159. doi: 10.1093/eurheartj/ehv205 pmid: 25994755
[8]	Yahagi K, Kolodgie F D, Otsuka F , et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis[J]. Nature Reviews Cardiology, 2016,13:79-98. doi: 10.1038/nrcardio.2015.164 pmid: 26503410
[9]	Lee C W, Kang S J, Park D W , et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation[J]. Journal of the American College of Cardiology, 2010,55:1936-1942. doi: 10.1016/j.jacc.2009.11.088 pmid: 20430265
[10]	Finn A V, Otsuka F . Neoatherosclerosis: a culprit in very late stent thrombosis[J]. Circulation Cardiovascular Interventions, 2012,5:6-9. doi: 10.1161/CIRCINTERVENTIONS.111.967927 pmid: 22338000
[11]	Warboys C M, De Luca A, Amini N , et al. Disturbed flow promotes endothelial senescence via a p53-dependent pathway[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2014,34:985-995. doi: 10.1161/ATVBAHA.114.303415 pmid: 24651677
[12]	Kimura T, Yokoi H, Nakagawa Y , et al. Three-year follow-up after implantation of metallic coronary-artery stents[J]. The New England Journal of Medicine, 1996,334:561-566. doi: 10.1056/NEJM199602293340903 pmid: 8569823
[13]	Chen M S, John J M, Chew D P , et al. Bare metal stent restenosis is not a benign clinical entity[J]. American Heart Journal, 2006,151:1260-1264. doi: 10.1016/j.ahj.2005.08.011 pmid: 16781233
[14]	Kimura T, Abe K, Shizuta S , et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries[J]. Circulation, 2002,105:2986-2991. doi: 10.1161/01.cir.0000019743.11941.3b pmid: 12081992
[15]	Yokoyama S, Takano M, Yamamoto M , et al. Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: from healing response to atherosclerotic transformation of neointima[J]. Circulation Cardiovascular Interventions, 2009,2:205-212. doi: 10.1161/CIRCINTERVENTIONS.109.854679 pmid: 20031717
[16]	Natsuaki M, Morimoto T, Furukawa Y , et al. Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2[J]. Circulation Cardiovascular Interventions, 2014,7(2):168-179. doi: 10.1161/CIRCINTERVENTIONS.113.000987 pmid: 24550439
[17]	Grube E, Dawkins K, Guagliumi G , et al. TAXUS Ⅵfinal 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions[J]. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009,4:572-577. doi: 10.4244/EIJV4I5A97
[18]	Kang S J, Park D W, Mintz G S , et al. Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis[J]. The American Journal of Cardiology, 2010,105:1402-1408. doi: 10.1016/j.amjcard.2009.12.064 pmid: 20451685
[19]	Nakazawa G, Vorpahl M, Finn A V , et al. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis[J]. JACC Cardiovascular Imaging, 2009,2:625-628. doi: 10.1016/j.jcmg.2009.01.011 pmid: 19442951
[20]	Romero M E, Yahagi K, Kolodgie F D , et al. Neoatherosclerosis from a pathologist's point of view[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2015,35:e43-e49. doi: 10.1161/ATVBAHA.115.306251 pmid: 26399921
[21]	Otsuka F, Vorpahl M, Nakano M , et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans[J]. Circulation, 2014,129:211-223. doi: 10.1161/CIRCULATIONAHA.113.001790
[22]	Yonetsu T, Kato K, Kim S J , et al. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry[J]. Circulation Cardiovascular Imaging, 2012,5:660-666. doi: 10.1161/CIRCIMAGING.112.976167 pmid: 22798521
[23]	Gomez-Lara J, Brugaletta S, Jacobi F , et al. Five-year optical coherence tomography in patients with ST-segment-elevation myocardial infarction treated with bare-metal versus everolimus-eluting stents[J]. Circulation Cardiovascular Interventions, 2016,9(10):e003670. doi: 10.1161/CIRCINTERVENTIONS.116.003670 pmid: 27702766
[24]	Taniwaki M, Windecker S, Zaugg S , et al. The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study[J]. European Heart Journal, 2015,36:2167-2176. doi: 10.1093/eurheartj/ehv227 pmid: 26040806
[25]	Habara M, Terashima M, Nasu K , et al. Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study[J]. Circulation Cardiovascular Interventions, 2011,4:232-238. doi: 10.1161/CIRCINTERVENTIONS.110.959999 pmid: 21610225
[26]	Takano M, Yamamoto M, Inami S , et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography[J]. Journal of the American College of Cardiology, 2009,55:26-32. doi: 10.1016/j.jacc.2009.08.032 pmid: 20117359
[27]	Kang S J, Mintz G S, Akasaka T , et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation[J]. Circulation, 2011,123:2954-2963. doi: 10.1161/CIRCULATIONAHA.110.988436
[28]	Raber L, Serruys P W . Late vascular response following drug-eluting stent implantation[J]. JACC Cardiovascular Interventions, 2011,4:1075-1078. doi: 10.1016/j.jcin.2011.06.016 pmid: 22017931
[29]	Joner M, Nakazawa G, Finn A V , et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents[J]. Journal of the American College of Cardiology, 2008,52:333-342. doi: 10.1016/j.jacc.2008.04.030
[30]	Torii R, Stettler R, Raber L , et al. Implications of the local hemodynamic forces on the formation and destabilization of neoatherosclerotic lesions[J]. International Journal of Cardiology, 2018,272:7-12. doi: 10.1016/j.ijcard.2018.06.065 pmid: 30293579

Basic and clinic advances of in-stent neoatherosclerosis

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References 30

Related Articles 2

Recommended Articles

Metrics

Comments

[1]	LIAO Xiaoping, YU Pujiao, XU Jiahong. Effectiveness of activation of sigma-1 receptor on reducing myocardium injury in ischemia reperfusion [J]. Journal of Shanghai University（Natural Science Edition）, 2018, 24(6): 853-860.
[2]	ZHAO Mengfei, MAO Liwei, JI Peng, HU Shugang, GAO Miao, WANG Lei. Effects of exercise on exercise capacity, cardiopulmonary function and cognitive function in elderly coronary heart disease patients with percutaneous coronary intervention [J]. Journal of Shanghai University（Natural Science Edition）, 2018, 24(2): 198-206.